Skip to content
PAD
DETOUR System
DETOUR System Reimbursement
DETOUR Professional Education
For PAD Patients
Find a Doctor
AAA
AAA
ALTO
AFX2
EVAR for Women
EVAR Portfolio Resources
Clinical Evidence
Procedural Training
IFU’s
About Us
About Us
News
The Team
Careers
Internal Applicant Portal
External Applicant Portal
Investigator Initiated
Research
Contact Us
PAD
DETOUR System
DETOUR System Reimbursement
DETOUR Professional Education
For PAD Patients
Find a Doctor
AAA
AAA
ALTO
AFX2
EVAR for Women
EVAR Portfolio Resources
Clinical Evidence
Procedural Training
IFU’s
About Us
About Us
News
The Team
Careers
Internal Applicant Portal
External Applicant Portal
Investigator Initiated
Research
Contact Us
Search
Back to News
May 16, 2016
Endologix Completes Patient Enrollment in the Ovation® LIFE (Least Invasive Fast-Track EVAR) Study
Prev
Previous
Positive Nellix Clinical Data from the ASCEND Study for the Treatment of Juxta and Pararenal AAA Presented at the 38th Annual Charing Cross Symposium
Next
Endologix Reports Positive Clinical Data from the Nellix EVAS FORWARD-IDE Study
Next
